Y0002253
Teriflunomide for assay
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 163451-81-8
Synonym(S): Teriflunomide, (Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide, A 1726, A77-1726, A771726, Flucyamide, HMR 1726, N-(4-Trifluoromethylphenyl)-2-cyano-3-hydroxycrotoamide, SU 20
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | Y0002253-50-MG | In Stock | ₹ 56,766.30 |
Y0002253 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 56,766.30
GST (18%): ₹ 10,217.934
Total Price: ₹ 66,984.234
API family
teriflunomide
manufacturer/tradename
EDQM
storage temp.
2-8°C
InChI
1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-
InChI key
UTNUDOFZCWSZMS-YFHOEESVSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Teriflunomide >=98% (HPLC) | 163451-81-8 | 10MG | -- | ₹ 8,339.30 | ||
Medchemexpress LLC HY-15405 500mg , Teriflunomide CAS:163451-81-8 Purity:>98% | -- | ₹ 18,503.10 | ||
Sigma Aldrich Fine Chemicals Biosciences Teriflunomide >=98% (HPLC) | 163451-81-8 | 50MG | -- | ₹ 35,106.05 | ||
Teriflunomide | -- | ₹ 28,437.28 | ||
Teriflunomide solution | -- | ₹ 16,492.00 | ||
2-Butenamide, 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-, (2Z)- | -- | ₹ 801.00 - ₹ 55,536.00 | ||
Teriflunomide | -- | ₹ 2,670.00 - ₹ 23,674.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Teriflunomide for assay EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Teriflunomide is an orally available anti-inflammatory immunomodulator. It blocks the activity of dihydroorotate dehydrogenase, preventing pyrimidine synthesis and T and B cell proliferation and function. Teriflunomide has been used to treat rheumatoid arthritis and was recently approved for multiple sclerosis.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable